The survival analysis of these group of genes MYH11, MYL9, PLN, THBS4, ITGA7, ACTG2, FLNA, KCNMB1, and MYLK also showed their significant prognostic power, which suggests that these groups of genes could be explored as prognostic biomarkers for the CRC. This evidence concerns the gene MYH11 and colorectal carcinoma.